Reviva Pharmaceuticals Holdings's total assets for Q2 2025 were $11.63M, an increase of 64.40% from the previous quarter. RVPH total liabilities were $12.09M for the fiscal quarter, a 4.83% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.